Navigation Links
America Hears Introduces New and Improved Hearing-Aid Programming Software
Date:11/4/2008

Online Hearing-Aid Manufacturer Will Sell Programming Kit and Software Separately From its Hearing Aids For the First Time

Bristol, PA (PRWEB) November 4, 2008 -- America Hears, Inc., the leading online supplier of premium digital hearing instruments, introduced a new and improved version of its hearing-aid programming software, Virtual Office, and announced it will sell Virtual Office separately from its hearing instruments for the first time. The new version of the software, which is the only product on the market enabling users to program their own digital hearing aids, is compatible with the Microsoft Vista operating system and provides a user interface that is as easy to work with as the graphic equalizer on a home stereo system.

America Hears will sell Virtual Office for an introductory price of $149 to customers who buy one or more new hearing instruments from America Hears. Along with the Virtual Office Software, customers will receive the Freedom Programmer and cables used to connect the user's hearing aids to a personal computer. Once connected, the hearing instruments can be programmed by the owner, or the audiologists and hearing instrument specialists at America Hears' Customer Service Center can make the adjustments and download them over the internet directly into the hearing instruments. Hearing-instrument customers who already own the America Hears programming software can download the new version of the software for free from the company's web site.

"Many America Hears customers are highly motivated by a 'do-it-yourself' ethic, but many want the help of our staff audiologists to adjust their hearing aids," said Henry C. Smith, CEO and founder of America Hears. "We are meeting the needs of both sets of customers with
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Campaign for Americas Future Memorandum: Katrina Storm Warning
6. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
7. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
8. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
9. Novo Nordisk Appoints New Leader of North American Business
10. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
11. America On the Move and More Than 1,500 YMCAs Kick Off Steptember 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
America Hears Introduces New and Improved Hearing-Aid Programming Software
America Hears Introduces New and Improved Hearing-Aid Programming Software
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects New Report Says 5006 1Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects New Report Says 5006 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects New Report Says 5006 3Anxious Kids at Risk for Obesity in Adulthood 57251 1Anxious Kids at Risk for Obesity in Adulthood 57251 2The Celebrate Wellness Expo Presents Motivational Speaker 26 Author Dr Robin L Smith and Spiritual Teacher 26 Author Rev Michael Bernard Beckwith 57249 1The Celebrate Wellness Expo Presents Motivational Speaker 26 Author Dr Robin L Smith and Spiritual Teacher 26 Author Rev Michael Bernard Beckwith 57249 2